نتایج جستجو برای: brca2 gene promoter

تعداد نتایج: 1174704  

Ahmad Mohamad Zaki, Amel Sobhy El Sedfy, Heba Gaber El-Sheredy, Ola Hussein Elgaddar, Sara Ahmed Aglan,

Background: ATP-binding cassette membrane transporter G2 (ABCG2) gene is one of transporter family and well characterized for their association with chemoresistance. Promoter methylation is a mechanism for regulation of gene expression. O6-Methyl guanine DNA methyl transferase (MGMT) gene plays a fundamental role in DNA repair. MGMT has the ability to remove alkyl adducts from DNA at the O6 pos...

Journal: :Journal of the National Cancer Institute 1998
D W Abbott M L Freeman J T Holt

BACKGROUND The protein product of the BRCA2 gene mediates repair of double-strand breaks in DNA. Because a number of cancer therapies exert cytotoxic effects via the initiation of double-strand breaks, cancers comprised of cells carrying BRCA2 gene mutations may be more amenable to treatment with agents that cause such breaks. METHODS We identified a human pancreatic adenocarcinoma cell line ...

Amirhosein Maali, Hamid Gholipour, Mehdi Azad, Mehrdad Noruzinia, Saeid Abroun, Sasan Ghaffari,

Background: Epigenetic modifications, such as methylation can occur in multiple myeloma. SMG1is an important gene involved in cell growth which defect in methylation of its promoter leads to reduction of cell apoptosis and uncontrolled proliferation. In this study, we identified the methylation status of the SMG1 gene promoter in patients with multiple myeloma. Methods: Methylation status of S...

لرکی, ثریا, ملکی, مسعود,

Background and objectives: Endometrial tissue growth and its activity outside the uterus cause endometriosis. It has been suggested that various epigenetic deviations play a major role in the pathogenesis of endometriosis. Steroidogenic factor 1 (SF-1; NR5A1) is an essential transcription factor for estrogen biosynthesis in endometrial cells. The expression of SF-1 in endometriosis and lack of ...

Journal: :middle east journal of cancer 0
narjes soltani cancer molecular pathology research center, ghaem hospital, faculty of medicine, mashhad university of medical sciences, mashhad, iran ehsan ghayoor karimiani hope genetic polyclinic, mashhad, iran mohammadreza farzanehfar department of internal medicine, ghaem hospital, faculty of medicine, mashhad university of medical sciences, mashhad, iran baratali mashkani department of medical biochemistry, faculty of medicine, mashhad university of medical sciences, mashhad, iran amirhossein jafarian cancer molecular pathology research center, department of pathology, faculty of medicine, mashhad university of medical sciences, mashhad, iran hami ashraf razavi cancer research center, research and education department, razavi hospital, mashhad, iran

background: colorectal cancer, the third most common type of cancer is a major cause of mortality worldwide. if colorectal cancer is detected at the early stages, the 5-year survival rate is 90%. meis1 homeobox gene is implicated in numerous solid tumors and hematological malignancies. therefore, the present study aims to investigate the methylation status of the meis1 gene in colorectal cancer...

Journal: :Journal of cell science 2010
Sergey Lekomtsev Julien Guizetti Andrei Pozniakovsky Daniel W Gerlich Mark Petronczki

Germline mutations in the tumor-suppressor gene BRCA2 predispose to breast and ovarian cancer. BRCA2 plays a well-established role in maintaining genome stability by regulating homologous recombination. BRCA2 has more recently been implicated in cytokinesis, the final step of cell division, but the molecular basis for this remains unknown. We have used time-lapse microscopy, recently developed ...

Journal: :Journal of medical genetics 2001
R B van der Luijt P H van Zon R P Jansen C J van der Sijs-Bos C C Wárlám-Rodenhuis M G Ausems

Germline mutations in either of the two major breast cancer predisposition genes, BRCA1 and BRCA2, account for a significant proportion of hereditary breast/ovarian cancer. Identification of breast cancer patients carrying mutations of these genes is primarily based on a positive family history of breast/ovarian cancer or early onset of the disease or both. In the course of mutation screening o...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2002
Nan Hu Guang Li Wen-Jun Li Chaoyu Wang Alisa M Goldstein Ze-Zhong Tang Mark J Roth Sanford M Dawsey Jing Huang Quan-Hong Wang Ti Ding Carol Giffen Philip R Taylor Michael R Emmert-Buck

PURPOSE Previous studies have shown a high rate of allelic loss in esophageal squamous cell carcinoma (ESCC) in the vicinity of the BRCA2 gene. We aimed to assess whether the tumor suppressor gene BRCA2 was the inactivation target for allelic loss observed on chromosome 13q in ESCC. EXPERIMENTAL DESIGN We examined the entire coding sequence of the BRCA2 gene for mutations using single-strand ...

2017
Glenn M. Manthey Alissa D. Clear Lauren C. Liddell Maria C. Negritto Adam M. Bailis

RAD52 is a homologous recombination (HR) protein that is conserved from bacteriophage to humans. Simultaneously attenuating expression of both the RAD52 gene, and the HR and tumor suppressor gene, BRCA2, in human cells synergistically reduces HR - indicating that RAD52 and BRCA2 control independent mechanisms of HR. We have expressed the human RAD52 gene (HsRAD52) in budding yeast strains lacki...

1998
Simon A. Gayther Bruce A. J. Ponder

The breast cancer susceptibility gene BRCA2 was isolated in 1995. BRCA2 is a large gene comprising 10,254 nucleotides and 26 coding exons. Neither the nucleotide nor the predicted protein sequences (comprising 3,418 amino acids) have provided substantial clues about its function. As a result, researchers have been trying to elucidate the function using a combination of cell biological and bioch...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید